If you want to reduce your DVT rate by 60-70%, HA-pneumonia and tissue injury cases by 20%, improve nursing productivity by 30%, and save your hospital millions each year, then contact VasoCARE.
THE LEGACY® IPC
VasoCARE provides the Legacy® IPC, the first and only device that weighs 70 grams, promotes frequent ambulation, improves nurse and patient compliance by over 80%, and reduces DVT by more than 60%. Legacy® IPC can help hospitals save millions each year by preventing HA-DVT, pneumonia, and tissue breakdown.
THE LEGACY® IPC Offers Hospitals Generational Platform Technology in Preventing Deep Vein Thrombosis (DVT), Pneumonia, and/or Tissue Injury.
Occurrence of DVT:
The rate of DVT with active adults is 0.4%. Hospitalize those same individuals and the rate increases to 5% and higher for high-risk patients. Being bed bound plays a major role in the development of DVT.
VasoCARE provides the VeinOPlus® Vascular device because this advanced neuro-muscular electrical stimulation device improves venous outflow 7x and arterial inflow 5x. Improving perfusion is the key in healing and preventing diabetic foot and venous leg ulcers.